Table 3.
Agreement between the results observed by 2-DE gel analysis and immunoblotting
2-DE Gels |
Immunoblotting |
|||||
---|---|---|---|---|---|---|
Protein | Spot # | MW (kDa) |
Changea | MW (kDa) |
Changea | Concordance |
Fibronectin | 17 | 218 | ↓ | 273 | ↓ | Yes |
Fibronectin | 23 | 133 | ↓ | 166 | ↓ | Yes |
Peroxiredoxin-1 | 18 | 23 | ↓ | 23 | ↓ | Yes |
Tenascin-C | 17 | 218 | ↓ | 260 | ↓ | Yes |
200 | – | No | ||||
↓ | 170 | ↓ | Yes | |||
↓ | 133 | ↓ | Yes | |||
GAPDH | 3 | 38 | ↑ | 36 | ↓ | No |
Peroxiredoxin-2 | 1 | 22 | ↑ | 23 | ↓ | No |
Peroxiredoxin-3 | 16 | 16 | ↓ | 23 | ↑ | No |
20 | ↓ | No | ||||
VDAC2 | 3 | 38 | ↑ | 38 | ↓ | No |
Apolipoprotein A1 | 1 | 22 | ↑ | 30 | – | No |
Collagen VI | 23 | 133 | ↓ | 100 | – | No |
myosin light chain 2 | 2 | 16 | ↓ | 20 | – | No |
Peroxiredoxin-6 | 18 | 23 | ↓ | 25 | – | No |
Direction of difference in spot and band intensity compared to WT; GAPDH – glyceraldehyde-3-phosphate dehydrogenase; VDAC2 – voltage-dependent anion channel 2